Pharvaris NV

Pharvaris NV Stock

—P/E
€2.02BMarket capitalisation
-€2.69Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel smallmolecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.

Pharvaris NV is registered in the following country: Netherlands (Exchange: USNASD).

Key metrics

Key metrics and master data for the Pharvaris NV stock.

Market capitalisation
€2.02B
P/E
—
P/B
7.60
P/S
—
P/CF
-11.47
Issued shares 65M Units

Return

Here you can see the performance of the Pharvaris NV stock.

PeriodPerfor­mance
1 Week-5.01 %
1 Month+7.77 %
3 Months-7.48 %
6 Months+15.65 %
1 Year+32.94 %
YTD+31.71 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Pharvaris NV share.

DateRatio
No data available.

Which ETF contains the Pharvaris NV stock?

The Pharvaris NV stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Pharvaris NV has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Pharvaris NV stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.